Navigation Links
Joslin Diabetes Center Names Boston Celtics Star Ray Allen to Board of Trustees
Date:5/18/2009

World's preeminent diabetes center looks to prominent father of child with type 1 diabetes to shine spotlight on the epidemic of the 21st century

BOSTON, May 18 /PRNewswire-USNewswire/ -- Joslin Diabetes Center today announced that it has appointed Boston Celtics star guard Ray Allen to its Board of Trustees. Allen is the father of a child with type 1 diabetes.

In June 2008, while the Celtics were in Los Angeles during their exciting run to become NBA champions, Allen's son Walker, 2, was diagnosed with type 1 diabetes. Since that time, Allen and his wife Shannon have enthusiastically embraced the Joslin Diabetes Center's mission and vision for a world without diabetes and its complications.

"When Walker was diagnosed with diabetes, our lives were thrown into a tailspin and Shannon and I needed all the information and support we could get as we learned how to manage our son's disease. We found that and more at the Joslin Diabetes Center," said Allen. "Being asked to join the Board of Trustees was not only a tremendous honor, but also felt like a natural fit since I believe in the great care Joslin provides and the research they are doing to someday cure diabetes."

"Since having the unique opportunity to get to know Ray, I can see that his belief in and commitment to our mission is deep and strong. I speak for the entire Joslin community when I say I am thrilled that he has joined our Board," said Ranch C. Kimball, President and CEO of Joslin Diabetes Center, an affiliate of Harvard Medical School.

From serving as co-chairs for the Joslin Diabetes Center's upcoming Bright Lights, High Hopes Gala on November 14, 2009 - World Diabetes Day, to Shannon being a co-captain of Team Joslin for the Boston Marathon, the Allen family has become a testament to the commitment needed in the fight against diabetes.

"As the father of a young child with diabetes, Ray brings a personal perspective and prominence that will help shine the spotlight on the Joslin Diabetes Center as we confront the growing challenge of diabetes," said Kevin E. Conley, Chairman of the Board of Trustees. "In just the period of time that Ray has been in the NBA, new cases of diabetes have almost doubled in the United States. Today, 24 million Americans have the disease."

During a reception at his home on May 15, Allen announced plans to raise $1 million for Joslin Diabetes Center at the November gala.

About Joslin Diabetes Center

Joslin Diabetes Center is the world's preeminent diabetes research and clinical care organization. Joslin Diabetes Center is dedicated to ensuring people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, M.D., Joslin Diabetes Center is an independent nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, call 1-800-JOSLIN-1 or visit www.joslin.org.


'/>"/>
SOURCE Joslin Diabetes Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Joslin launches national study to explore if anti-inflammatory drug can treat type 2 diabetes
2. Joslin researcher named first winner of the Manpei Suzuki International Prize for Diabetes Research
3. Joslin study finds restricting insulin doses increases mortality risk
4. Seattle Laces Up to Beat the Bridge and Diabetes
5. Scienceroll.com on Diabetes 2.0, a Free Online Resource for Diabetes Patients
6. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
7. Old diabetes drug teaches experts new tricks
8. Can New Surgery Revolutionize Diabetes Treatment?
9. Diabetes Experts Partner With Novo Nordisk to Provide New Patient Materials
10. Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17
11. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... PITTSBURGH, PA (PRWEB) , ... July 20, 2017 , ... ... is of utmost importance. The adjustable beds used in such facilities are specially designed ... not feature adequate arm support. , An inventor from Rochester, Ind., has invented ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced ... Proceeds will be used to complete regulatory submissions and fund final engineering and ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... that further expand its existing adherence automation lines. The ATP® Mini and ... advanced technology of TCG’s standard products, but at a size and price point ...
(Date:7/20/2017)... , ... July 20, 2017 , ... A budget proposal ... cost – of - living - adjustment (COLA) is a bad deal for older ... “chained” consumer price index (CPI) would grow even more slowly than the conventional one ...
(Date:7/20/2017)... , ... July 19, 2017 , ... At Creekwood Dental ... of temporomandibular joint (TMJ) treatment and dental implants in Waco, TX, using ... scanner and the T-Scan™ by Tekscan®, they can capture details in the oral cavity ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: